EFFECT OF MORPHOLOGICAL ABNORMALITIES ON BLOOD RETINAL BARRIER PERMEABILITY IN DIABETIC-RETINOPATHY

被引:6
作者
VANGERVEN, JMA
BOOT, JP
LEMKES, HHPJ
VANBEST, JA
机构
[1] LEIDEN UNIV HOSP,DEPT OPHTHALMOL,RIJNSBURGERWEG 10,2333 AA LEIDEN,NETHERLANDS
[2] LEIDEN UNIV HOSP,DEPT ENDOCRINOL & METABOL DIS,2333 AA LEIDEN,NETHERLANDS
关键词
DIABETES-MELLITUS; DIABETIC RETINOPATHY; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; FUNDUS PHOTOGRAPHY; VITREOUS FLUOROPHOTOMETRY;
D O I
10.1007/BF00161244
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The morphological base for the impaired function of the blood retinal barrier was studied in 50 eyes of 10 insulin dependent and 21 non-insulin dependent patients with various levels of diabetic retinopathy. The permeability of the blood retinal barrier (P(BRB)) was determined by vitreous fluorophotometry with correction for autofluorescence, lenstransmission and non-protein bound plasma fluorescein concentration. Morphological abnormalities of diabetic retinopathy assessed by fundus photography and fluorescein angiography were individually scored on a decimal scale and related to the P(BRB) by multiple regression analysis. The P(BRB) was not correlated to morphological abnormalities of non-proliferative retinopathy [(1) microaneurysms, (2) hard exudates, (3) soft exudates, (4) intraretinal hemorrhages, (5) fluorescein leakage, and (6) capillary closure, p > 0.31. The P(BRB) was correlated to morphological abnormalities of (pre)proliferative retinopathy [(1) intraretinal microvascular abnormalities (S(IRMA)) and (2) new vessels (S(neo)): P(BRB) = A + B.S(IRMA) + C.S(neo) with P.. in nm/sec, A = 1.5 +/- 0.5, B = 0.9 +/- 0.2 and C = 1.7 +/- 0.4, R2 = 0.65, p < 0.0001]. It can be concluded that the increased blood retinal barrier permeability in diabetic patients is mainly due to (pre)proliferative abnormalities and not to non-proliferative abnormalities.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 21 条
  • [1] ARMITAGE P, 1987, STATISTICAL METHODS, P194
  • [2] PLASMA FLUORESCEIN DECAY DETERMINATION DURING FLUOROPHOTOMETRY
    BOOT, JP
    VANBEST, JA
    TSOI, EWSJTA
    KAPPELHOF, JP
    OOSTERHUIS, JA
    [J]. DOCUMENTA OPHTHALMOLOGICA, 1987, 65 (04) : 403 - 422
  • [3] BURSELL SE, 1984, INVEST OPHTH VIS SCI, V25, P703
  • [4] VITREOUS FLUOROPHOTOMETRY IN PATIENTS WITH NO OR MINIMAL DIABETIC-RETINOPATHY
    CHAHAL, P
    FALLON, TJ
    JENNINGS, SJ
    CHOWIENCZYK, PJ
    KOHNER, EM
    [J]. DIABETES CARE, 1986, 9 (02) : 134 - 139
  • [5] CUNHAVAZ J, 1975, BRIT J OPHTHALMOL, V59, P649, DOI 10.1136/bjo.59.11.649
  • [6] CUNHAVAZ JG, 1979, OPHTHALMOLOGY, V86, P264
  • [7] CHARACTERIZATION OF THE EARLY STAGES OF DIABETIC-RETINOPATHY BY VITREOUS FLUOROPHOTOMETRY
    CUNHAVAZ, JG
    GRAY, JR
    ZEIMER, RC
    MOTA, MC
    ISHIMOTO, BM
    LEITE, E
    [J]. DIABETES, 1985, 34 (01) : 53 - 59
  • [8] KAPPELHOF JP, 1987, INVEST OPHTH VIS SCI, V28, P665
  • [9] KAYAZAWA F, 1984, ANN OPHTHALMOL, V16, P221
  • [10] KJAERGAARD JJ, 1983, INT J MICROCIRC, V2, P207